Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center

被引:9
|
作者
Fritz, Megan Kunka [1 ]
Kincaid, Scott E. [1 ]
Sargent, Charles G. [2 ]
Green, Amanda H. [3 ]
Davis, George A. [1 ]
机构
[1] Univ Kentucky HealthCare, Pharm Dept, 800 Rose St, Lexington, KY 40536 USA
[2] Univ Kentucky HealthCare, Div Hosp Med, 800 Rose St, Lexington, KY 40536 USA
[3] Univ Kentucky HealthCare, Dept Nursing, 800 Rose St, Lexington, KY 40536 USA
关键词
Venous thromboembolism; Classification; Risk factors; Low molecular weight heparin; Heparin; PROPHYLAXIS; PREVENTION; GUIDELINES; THROMBOSIS; MODEL;
D O I
10.1007/s11239-020-02144-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hospital-acquired venous thromboembolism (VTE) is still a concern for general medical patients. Pharmacologic prophylaxis can reduce VTE incidence, but there is the potential for adverse effects. Therefore, determining which patients should receive VTE prophylaxis via risk scoring tools is essential. Limited evidence exists for the ideal venous thromboembolism risk assessment model (RAM) in hospitalized medical patients, as compared to other hospitalized patient subgroups such as surgical patients. The primary objective was to investigate the utilization and appropriateness of our institution-based VTE RAM and comparison to the Padua Prediction Score (PPS). This would allow for a gauge of provider risk assessment accuracy as well as appropriate predictive potential of the PPS or whether an alternative to the PPS should be considered. A total of 330 adult general medicine patients were included in this retrospective chart review. When compared to our institution-based VTE RAM, providers predominately stratified patients at a higher VTE risk than the institution-based VTE RAM. VTE incidence was 0.3%, which was lower than predicted. Significant discordance exists between providers' VTE risk assessment and that predicted by RAMs. Our institution-based VTE RAM appears comparable to PPS; however, it was not being utilized by providers, resulting in potentially unnecessary use of pharmacologic prophylaxis. The most appropriate venous thromboembolism risk assessment model for general medicine patients is undetermined. Our providers generally assess patients as moderate or high VTE risk, despite our institution-based RAM which typically recommends a lower risk category than provider selection. Because of provider risk assessment, more patients received pharmacologic VTE prophylaxis than would have been recommended by the RAM, which might correlate to the low incidence of VTE which was < 0.5%, although bleeding complications were not assessed in this study. A prospective study utilizing the Padua Prediction Score (or similar RAM) in general medicine patients is warranted in order to decipher the best method of predicting VTE risk.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 50 条
  • [21] Venous Thromboembolism Prophylaxis for Medical Patients
    Varughese, Jay
    Jenkins, Ian
    HOSPITAL MEDICINE CLINICS, 2012, 1 (02) : E238 - +
  • [22] Venous thromboembolism prophylaxis in medical patients
    Michota, FA
    CURRENT OPINION IN CARDIOLOGY, 2004, 19 (06) : 570 - 574
  • [23] Preventing venous thromboembolism in medical patients
    Leizorovicz, A
    Mismetti, P
    CIRCULATION, 2004, 110 (24) : 13 - 19
  • [24] Low persistence to rivaroxaban or warfarin among patients with new venous thromboembolism at a safety net academic medical center
    Sweta Meet Patel
    Tina Wang
    Desire Lashalle Outler
    Jennifer Elliott
    Michael Knauss
    Samuel K. Peasah
    Mikhail Akbashev
    Journal of Thrombosis and Thrombolysis, 2020, 49 : 287 - 293
  • [25] Low persistence to rivaroxaban or warfarin among patients with new venous thromboembolism at a safety net academic medical center
    Patel, Sweta Meet
    Wang, Tina
    Outler, Desire Lashalle
    Elliott, Jennifer
    Knauss, Michael
    Peasah, Samuel K.
    Akbashev, Mikhail
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (02) : 287 - 293
  • [26] Does ambulation modify venous thromboembolism risk in acutely ill medical patients?
    Amin, Alpesh N.
    Girard, Frederick
    Samama, Meyer M.
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (05) : 955 - 961
  • [27] Risk stratification for hospital-acquired venous thromboembolism in medical patients (RISE): Protocol for a prospective cohort study
    Choffat, Damien
    Farhoumand, Pauline Darbellay
    Jaccard, Evrim
    de la Harpe, Roxane
    Kraege, Vanessa
    Benmachiche, Malik
    Gerber, Christel
    Leuzinger, Salome
    Podmore, Clara
    Truong, Minh Khoa
    Dumans-Louis, Celine
    Marti, Christophe
    Reny, Jean-Luc
    Aujesky, Drahomir
    Rakovic, Damiana
    Limacher, Andreas
    Rossel, Jean-Benoit
    Baumgartner, Christine
    Mean, Marie
    PLOS ONE, 2022, 17 (05):
  • [28] Venous Thromboembolism Risk Stratification: The Missing Link in Hospitalized Patients
    Al-Ogaili, Ahmed
    Quintero, Luis Diaz
    Adum, Juan Pablo Salazar
    Fuentes, Harry E.
    Caprini, Joseph
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (11) : 1087 - 1088
  • [29] Venous thromboembolism prophylaxis in medical patients: Future perspectives
    Imberti, D
    Prisco, D
    THROMBOSIS RESEARCH, 2005, 116 (05) : 365 - 375
  • [30] Stratification of venous thromboembolism risk in stroke patients by Caprini score
    Zhu, Xiaoping
    Zhang, Tingting
    Zhou, Lanshu
    Yin, Xiaobing
    Dong, Qiong
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (03) : 631 - 636